Two Sigma Advisers
SVA

Two Sigma Advisers’s Sinovac Biotech, Ltd SVA Stock Holding History

Two Sigma Advisers’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-30,400
Closed -$214K – 2502
2017
Q3 		$214K Sell
30,400
-6,200
-17% -$42.3K ﹤0.01% 2038
2017
Q2 		$247K Buy
36,600
+1,300
+4% +$7.12K ﹤0.01% 2053
2017
Q1 		$202K Buy
35,300
+2,400
+7% +$13.9K ﹤0.01% 2204
2016
Q4 		$194K Sell
32,900
-800
-2% -$4.81K ﹤0.01% 2199
2016
Q3 		$199K Sell
33,700
-6,800
-17% -$40K ﹤0.01% 2043
2016
Q2 		$240K Sell
40,500
-7,900
-16% -$48.4K ﹤0.01% 1807
2016
Q1 		$309K Buy
48,400
+2,200
+5% +$13.2K ﹤0.01% 1652
2015
Q4 		$264K Sell
46,200
-1,200
-3% -$6.46K ﹤0.01% 1566
2015
Q3 		$241K Hold
47,400
– – ﹤0.01% 1579
2015
Q2 		$249K Sell
47,400
-4,100
-8% -$21.7K ﹤0.01% 1687
2015
Q1 		$255K Sell
51,500
-30,700
-37% -$151K ﹤0.01% 1647
2014
Q4 		$430K Sell
82,200
-12,100
-13% -$61.7K ﹤0.01% 1713
2014
Q3 		$454K Sell
94,300
-500
-0.5% -$2.68K ﹤0.01% 1602
2014
Q2 		$535K Buy
94,800
+7,500
+9% +$45.6K ﹤0.01% 1633
2014
Q1 		$630K Buy
+87,300
New +$578K 0.01% 1432

Other funds holding SVA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Two Sigma Advisers's SVA Position: Q4 2017 in Review

Two Sigma Advisers sold out of Sinovac Biotech, Ltd (SVA) in Q4 2017, closing a stake of 30,400 shares — an estimated $214K sold.

Two Sigma Advisers first reported a position in SVA in Q1 2014 and held it in 15 quarters. The position peaked at $630K in Q1 2014. 31 funds tracked by Wall St. Rank hold SVA as of Q4 2017.

  • Two Sigma Advisers reported no remaining Sinovac Biotech, Ltd position as of Q4 2017 after selling out during the quarter.
  • Two Sigma Advisers sold 30,400 Sinovac Biotech, Ltd shares in Q4 2017, an estimated $214K.
  • Two Sigma Advisers first reported a position in Sinovac Biotech, Ltd in Q1 2014 and held it in 15 quarters.
  • Two Sigma Advisers's Sinovac Biotech, Ltd position peaked at $630K in Q1 2014.
  • 31 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q4 2017.

Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.